2025-04-09 - Analysis Report
## UnitedHealth Group Inc. (UNH) Stock Review

**0. Key Figures Overview:**

UNH has significantly outperformed the S&P 500 (VOO) over the period considered.  While precise timeframe isn't specified, the cumulative return difference is substantial. The recent price shows a sharp increase compared to the moving averages, suggesting potential overvaluation or a temporary surge. Profitability indicators are generally strong, though some recent quarterly results show volatility.


**1. Performance Comparison and Alpha/Beta Analysis:**

UnitedHealth Group Inc. (UNH) is a diversified healthcare company.

* **Cumulative Return:** UNH: 66.59%, VOO: 56.10%.  UNH outperformed VOO by 10.49% at the end of the period.
* **Relative Outperformance:** The provided relative outperformance of 54.2% places UNH's performance in the upper percentile of its historical performance relative to the S&P 500.  This doesn't necessarily indicate future outperformance.

The Alpha/Beta analysis shows mixed results:

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) | UNH CAGR vs VOO CAGR |
|------------|------|------|-------|------|-------|-----------------------|
| 2015-2017  | 64.0% | 56.1% | 35.0% | 0.1 | 181.1 | 64.0 - (Assumed VOO CAGR)|
| 2016-2018  | 55.0% | 63.9% | 37.0% | 0.2 | 207.4 | 55.0 - (Assumed VOO CAGR)|
| 2017-2019  | 41.0% | 63.9% | 11.0% | 0.3 | 248.8 | 41.0 - (Assumed VOO CAGR)|
| 2018-2020  | -20.0% | 63.9% | -45.0% | 0.5 | 301.7 | -20.0 - (Assumed VOO CAGR)|
| 2019-2021  | 34.0% | 60.8% | -20.0% | 0.6 | 438.1 | 34.0 - (Assumed VOO CAGR)|
| 2020-2022  | 28.0% | 67.1% | 22.0% | 0.6 | 468.5 | 28.0 - (Assumed VOO CAGR)|
| 2021-2023  | 35.0% | 67.6% | 18.0% | 0.4 | 472.2 | 35.0 - (Assumed VOO CAGR)|
| 2022-2024  | -27.0% | 68.8% | -44.0% | 0.3 | 460.9 | -27.0 - (Assumed VOO CAGR)|
| 2023-2025  | -11.0% | 73.2% | -14.0% | 0.1 | 505.6 | -11.0 - (Assumed VOO CAGR)|

**Note:**  To complete the last column,  the Compound Annual Growth Rate (CAGR) for VOO for each period is needed.  The provided data only offers the final cumulative return for VOO.


**2. Recent Price Movement:**

* **Closing Price:** $552.625
* **Last Market Price:** $552.76 (a $5.35 increase from the previous close)
* **5-Day Moving Average:** $532.887
* **20-Day Moving Average:** $511.9782
* **60-Day Moving Average:** $511.3553

The recent price is significantly above all moving averages, suggesting a potential short-term overbought condition.  The sharp increase from the previous close ($5.35) indicates a rapid upward movement.


**3. Technical Indicators and Expected Return:**

* **Market Risk Indicator (MRI):** 0.4883 (High Risk category)
* **RSI:** 76.01 (Overbought territory, suggesting potential price correction)
* **PPO:** 0.77 (Positive, indicating upward momentum)
* **Relative Strength Change (20-day):** 27.7% (+), confirming short-term upward trend.
* **Expected Return:** 11.9% (long-term, over 2 years, exceeding S&P 500 returns).

The high RSI and MRI suggest caution. While the positive PPO and recent price movement indicate upward momentum, the risk of a correction is high.



**4. Recent Earnings Analysis:**

| Date       | EPS   | Revenue       | Notes                                   |
|------------|-------|---------------|----------------------------------------|
| 2024-11-04 | 6.56  | $100.82 B     |                                        |
| 2024-08-09 | 4.58  | $98.86 B     |                                        |
| 2024-05-09 | -1.53 | $99.80 B     | Significant loss in this quarter         |
| 2023-11-06 | 6.31  | $92.36 B     |                                        |
| 2024-11-04 | 6.31  | $92.36 B     | Duplicate entry - likely a data error  |


Revenue remains relatively stable, but EPS shows significant volatility, with a substantial loss in Q2 2024.  The duplicate entry needs clarification.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue     | Profit Margin |
|---------|-------------|---------------|
| 2024-12-31 | $100.81B   | 21.14%        |
| 2024-09-30 | $100.82B   | 22.84%        |
| 2024-06-30 | $98.86B    | 22.31%        |
| 2024-03-31 | $99.80B    | 23.05%        |
| 2023-12-31 | $94.43B    | 23.30%        |

Profit margins are consistently high but show slight decline in recent quarters.

**Capital and Profitability:**

| Quarter | Equity      | ROE      |
|---------|-------------|----------|
| 2024-12-31 | $92.66B    | 5.98%    |
| 2024-09-30 | $94.53B    | 6.41%    |
| 2024-06-30 | $89.36B    | 4.72%    |
| 2024-03-31 | $86.69B    | -1.63%   | Negative ROE in Q1 2024
| 2023-12-31 | $88.76B    | 6.15%    |

ROE is also volatile, with a negative value in Q1 2024, highlighting the need for further investigation into the Q2 2024 EPS loss.


**6. Overall Analysis:**

UNH has historically outperformed the S&P 500, showing a strong long-term growth potential. However, recent data reveals some concerns:  the significant price increase relative to moving averages indicates a potentially overvalued short-term position. The high RSI and MRI suggest a high risk of a price correction. The recent earnings show volatility, particularly the substantial loss in Q2 2024 and needs further explanation.  While long-term prospects remain positive based on historical performance and expected return, a cautious approach is advised given the current overbought condition and volatility in recent financial performance.  More investigation is necessary to understand the reason for the Q2 2024 loss and the duplicate earnings data point.
